Skip to main content

Generalized Anxiety Disorder

  • Chapter
  • 2378 Accesses

Part of the book series: Current Clinical Practice ((CCP))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hollander E, Simeon D. Anxiety disorders. In: Hales R, Yudofsky S, eds. Textbook of Clinical Psychiatry, 4th ed. Washington, DC: American Psychiatric Publishing, 2003:543–630.

    Google Scholar 

  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision (DSM-IV-TR). Arlington, VA: American Psychiatric Publishing, 2000:222–223.

    Google Scholar 

  3. Shelton R. Anxiety disorders. In: Ebert M, Loosen P, Nurcombe B, eds. Current Diagnosis and Treatment in Psychiatry. New York: McGraw-Hill, 2000:328–340.

    Google Scholar 

  4. Gliatto M. Generalized anxiety disorder. Am Fam Physician 2000;62(7): 1501–1502.

    Google Scholar 

  5. Kniele K, Brawman-Mintzer O. Diagnosis and treatment of generalized anxiety disorder. CNS News 2006;8(7):17–23.

    Google Scholar 

  6. Jetty P, Charney D, Goddard A. Neurobiology of generalized anxiety disorder. Psychiatric Clin North Am 2001;24(1):75–97.

    Article  CAS  Google Scholar 

  7. Kendler K. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 2006;163(7):1138–1146.

    Article  PubMed  Google Scholar 

  8. Mathew S. Glutamate modulation in mood and anxiety disorders: toward a rational pharmacology? CNS Spectrums 2005;10(10):806–807.

    Google Scholar 

  9. Cortese B, Phan K. The role of glutamate in anxiety and related disorders. CNS Spectrums 2005;10(10):820–830.

    PubMed  Google Scholar 

  10. Spitzer R, Kroeneke K, Williams J, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092–1097.

    Article  PubMed  Google Scholar 

  11. Sajatovic M, Ramirez L. Rating Scales in Mental Health, 2nd ed. Hudson, OH: Lexi-Comp, 2003:36–44.

    Google Scholar 

  12. Chan P, Thomas D, McKinley E, Stanford E. Outpatient and Primary Care Medicine. Laguna Hills, CA: Current Clinical Strategies Publishing, 2005:233–255.

    Google Scholar 

  13. Pollack M. Comorbid anxiety and depression. J Clin Psychiatry 2005;66(suppl 8):22–29.

    CAS  PubMed  Google Scholar 

  14. Ninan P. Dissolving the burden of generalized anxiety disorder. J Clin Psychiatry 2001:62(suppl 19):5–10.

    PubMed  Google Scholar 

  15. Rynn M, Brawman-Mintzer O. Generalized anxiety disorder: acute and chronic treatment. CNS Spectrums 2004;9(10):716–723.

    PubMed  Google Scholar 

  16. Ballenger J. Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. J Clin Psychiatry 2001;62(suppl 19):11–19.

    CAS  PubMed  Google Scholar 

  17. Ballenger J, et al. A proposed algorithm for the improved recognition and treatment of the depression/anxiety spectrum in primary care. J Clin Psychiatry Prim Care Companion 2001;3(2):44–52.

    Article  Google Scholar 

  18. Brawman-Mintzer O, Knapp R, Rynn M, Carter R, Rickels K. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2006;67(6):874–881.

    Article  CAS  PubMed  Google Scholar 

  19. Marangell L, Silver J, Goff D, Yudosfsky S. Psychopharmacology and electroconvulsive therapy. In: Hales R, Yudofsky S, ed. Textbook of Clinical Psychiatry, 4th ed. Washington, DC: American Psychiatric Publishing, 2003:1047–1149.

    Google Scholar 

  20. Dunner D, et al. Duloxetine in treatment of anxiety symptoms associated with depression. Depression and Anxiety 2003;18:53–61.

    Article  CAS  PubMed  Google Scholar 

  21. Stahl S, Grady M, Moret C, Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectrums 2005;10(9):732–747.

    PubMed  Google Scholar 

  22. Loosen P, et al. Mood disorders. In: Ebert M, Loosen P, Nurcombe B, eds. Current Diagnosis and Treatment in Psychiatry. New York: McGraw-Hill, 2000:290–327.

    Google Scholar 

  23. Larun L, Nordheim L, Ekeland E, Hagen K, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database of Systematic Reviews 2006;3: CD004691. DOI: 10.1002/14651858.CD004691.pub2.

    Google Scholar 

  24. Rasmussen K. Creating more effective antidepressants: clues from the clinic. Drug Discovery Today 2006;11(13/14):623–631.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press

About this chapter

Cite this chapter

Helsley, J.D. (2008). Generalized Anxiety Disorder. In: Anxiety Disorders. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-263-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-263-2_12

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-923-9

  • Online ISBN: 978-1-59745-263-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics